Axsome Therapeutics Has Initiated ENGAGE Phase 3 Trial Of Solriamfetol, An Investigational Treatment For Binge Eating Disorder In Adults
Axsome Therapeutics已啓動Solriamfetol的ENGAGE三期試驗,這是一種治療成人暴飲暴食症的研究性治療方法
Axsome Therapeutics Has Initiated ENGAGE Phase 3 Trial Of Solriamfetol, An Investigational Treatment For Binge Eating Disorder In Adults
Axsome Therapeutics已啓動Solriamfetol的ENGAGE三期試驗,這是一種治療成人暴飲暴食症的研究性治療方法
使用瀏覽器的分享功能,分享給你的好友吧